Optical molecular imaging developer ART Advanced Research Technologies will receive an additional investment of $5.9 million (U.S.) from longtime shareholder OppenheimerFunds.
The Montreal-based firm said it would use the net proceeds as working capital and to finance corporate development.
By AuntMinnie.com staff writers
July 12, 2005
Related Reading
ART sales up, but loss grows, May 9, 2005
GE, ART sell SAMI to Novartis, October 21, 2003
GE, ART alliance notch first sale, September 23, 2003
ART starts clinical trials, September 19, 2003
GE expands ART relationship, August 14, 2003
Copyright © 2005 AuntMinnie.com
